Krishnan Nandabalan
Director, BioXcel Therapeutics, Inc.
Companies
- BioXcel Therapeutics, Inc.Board member Mar 7, 2018 to Apr 10, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- BioXcel Therapeutics, Inc. BTAIQ8,546,750 shares2$213.7K at $0.03Apr 10, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 6, 2023Sold 60,000 shares at $17.32 of BioXcel Therapeutics, Inc.2
- Apr 6, 2023Exercised options 60,000 shares at $0.41 of BioXcel Therapeutics, Inc.2
- Jan 5, 2023Sold 800 shares at $22.93 of BioXcel Therapeutics, Inc.3
- Jan 5, 2023Sold 25,089 shares at $22.32 of BioXcel Therapeutics, Inc.3
- Jan 5, 2023Exercised options 25,889 shares at $0.41 of BioXcel Therapeutics, Inc.3
- Jan 4, 2023Sold 9,821 shares at $22.21 of BioXcel Therapeutics, Inc.3
- Jan 4, 2023Sold 24,290 shares at $21.59 of BioXcel Therapeutics, Inc.3
- Jan 4, 2023Exercised options 34,111 shares at $0.41 of BioXcel Therapeutics, Inc.3
- Nov 15, 2022Gift 291,097 shares of BioXcel Therapeutics, Inc.4
- Nov 15, 2022Gift 291,097 shares of BioXcel Therapeutics, Inc.4
- Nov 15, 2022Gift 145,549 shares of BioXcel Therapeutics, Inc.4
- Nov 11, 2022Sold 32,550 shares at $15.00 of BioXcel Therapeutics, Inc.5
- Nov 11, 2022Exercised options 32,550 shares at $0.41 of BioXcel Therapeutics, Inc.5
- Nov 10, 2022Sold 27,450 shares at $15.00 of BioXcel Therapeutics, Inc.5
- Nov 10, 2022Exercised options 27,450 shares at $0.41 of BioXcel Therapeutics, Inc.5
- Apr 6, 2021Gift 102,568 shares of BioXcel Therapeutics, Inc.6
- Apr 6, 2021Gift 130,659 shares of BioXcel Therapeutics, Inc.6
- Apr 6, 2021Gift 130,659 shares of BioXcel Therapeutics, Inc.6
- Apr 6, 2021Gift 102,568 shares of BioXcel Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 6, 2023
- 4SEC EDGARForm 5 filed Feb 14, 2023
- 5SEC EDGARForm 4 filed Nov 14, 2022
- 6SEC EDGARForm 5 filed Feb 14, 2022